Infosys (NYSE: INFY) reported better-than-expected earnings for the third quarter of 2020 while revenue matched forecasts. Shares were up 6.5% in premarket hours on Friday.
Total revenues increased 8.6% year-over-year to $3.24 billion, coming in line with estimates. Revenues increased 9.5% in constant currency.
Net income was $627 million, or $0.15 per share, compared to $502 million, or $0.12 per share, last year. Analysts had forecast earnings of $0.14 per share.
Nilanjan Roy, CFO, said “Operating margins improved further during the quarter driven by relentless cost optimization and operating leverage. Cash generation was extremely strong with cumulative free cash flow crossing $1.5 billion. Return on Equity increased further to 25.9% driven by margin expansion and increased shareholder payouts.”
Digital revenues grew around 40% year-over-year to $1.31 billion while core revenues fell nearly 6% to $1.92 billion. Large deal signings during the quarter amounted to $1.8 billion.
The number of $100 million-clients totaled 28 at the end of the quarter and the number of $50 million-clients amounted to 61. The top 25 clients contributed 34.2% to total revenues during the quarter.
Operating profit increased 5.4% year-over-year to $711 million. Operating margin was 21.9%.
For fiscal year 2020, the company expects revenue to grow 10-10.5% in constant currency. Operating margin is expected to grow 21-23%.
In a separate press release, Infosys stated that its audit committee found no evidence of financial impropriety or executive misconduct during its investigation related to whistleblower complaints.
Biotechnology company Monte Rosa Therapeutics is slated to go public this week. In a pandemic-ridden world, this industry is expanding at a healthy pace. The global biotechnology market is estimated
The healthcare sector is going through a phase of consolidation, creating fresh opportunities for emerging companies in a market that is slowly recovering from the pandemic. Several pharmaceuticals firms have
Shares of American Airlines Group (NASDAQ: AAL) have gained 42% since the beginning of this year and 50% over the past 12 months. Despite this, there is a mixed sentiment